Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Panciu, Traian Constantin; Masgras, Bianca; Ciuca, Catrinel; Ciomag, Raluca; Mihăilescu, Anca; Gurghean, Adriana

Acceso abierto

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Traian Constantin Panciu

Panciu, Traian Constantin

,

,

,

,

y

20 jul 2018

Volumen 15 (2018): Edición 3 (Julio 2018)

Acerca de este artículo

Artículo anterior

Artículo siguiente

Cite

Descargar portada

Publicado en línea: 20 jul 2018

Páginas: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

Palabras clave
Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Panciu, Traian Constantin

Clinical Hospital Colţea Bucharest

Masgras, Bianca

Clinical Hospital Colţea Bucharest

Ciuca, Catrinel

Clinical Hospital Colţea Bucharest

Ciomag, Raluca

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Mihăilescu, Anca

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Gurghean, Adriana

Clinical Hospital Colţea Bucharest

University of Medicine and Pharmacy Carol Davila BucharestRomania

Idioma:: Inglés

Calendario de la edición:: 4 veces al año
Temas de la revista:: Medicina, Medicina Clínica, Medicina Interna, Medicina Interna, otros, Cardiología, Gastroenterología, Neumología

RSS Feed de revista

Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Traian Constantin Panciu

Bianca Masgras

Catrinel Ciuca

Raluca Ciomag

Anca Mihăilescu

Adriana Gurghean

Publicado en línea: 20 jul 2018

Páginas: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

Palabras claveErlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Palabras clave
Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome